COVID-19 Vaccine Safety Technical (VaST) Work Group

“VaST Discussion and Interpretation:

• Data available to date suggest likely association of myocarditis with mRNA vaccination in adolescents and young adults.
• Clinical presentation of myocarditis cases following vaccination has been distinct, occurring most often within one week after dose 2, with chest pain as the most common.
• Further data are being compiled to understand potential risk factors, optimal management strategies, and long-term outcomes.”